Now, Bharat Biotech seeks emergency use approval for COVAXIN

After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN. The vaccine is being developed indigenously by the Hyderabad-based company and the Indian Council of Medical Research (ICMR), the top government body leading the fight against coronavirus. The vaccine is currently in phase three trials. Here's more.

source https://www.newsbytesapp.com/news/india/bharat-biotech-seeks-emergency-use-approval-for-covaxin/story